NextCure
NXTC
88 hedge funds and large institutions have $1.14B invested in NextCure in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 6 closing their positions.
600% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 6
227% more capital invested
Capital invested by funds: $348M → $1.14B (+$789M)
142% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 12
69% more funds holding
Funds holding: 52 → 88 (+36)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
1.99% more ownership
Funds ownership: 4.14% → 6.13% (+2%)
68% less call options, than puts
Call options by funds: $444K | Put options by funds: $1.37M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$47.4M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$39.5M |
| 3 |
BlackRock
New York
|
+$36.1M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$29.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MICM
Matthews International Capital Management
San Francisco,
California
|
-$12.4M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$7.73M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$6.01M |
| 4 |
YU
Yale University
New Haven,
Connecticut
|
-$3.84M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.62M |
NXTC Hedge Fund Activity: Q4 2019 in Review
88 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2019, worth a combined $1.14B — up 227% from $348M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new NXTC positions and 6 closed out — a net gain of 36 holders — while 29 added to existing stakes and 12 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $47.4M. The largest seller was Matthews International Capital Management, cutting an estimated $12.4M.
- 88 institutional investors held NextCure (NXTC) as of Q4 2019, up from 52 in Q3 2019.
- Funds reported $1.14B of NextCure stock for Q4 2019, up 227% quarter-over-quarter.
- 42 funds opened new NextCure positions in Q4 2019 and 6 closed out, a net change of +36 holders.
- The largest NextCure buyer in Q4 2019 was Great Point Partners, an estimated $47.4M added.
- The largest NextCure seller in Q4 2019 was Matthews International Capital Management, an estimated $12.4M sold.
Based on aggregated 13F filings for Q4 2019.